Objective To study the value and curative effect of TACE on hepatocellular carcinoma.
目的探討肝動(dòng)脈化療栓塞術(shù)(TACE)治療肝癌的臨床療效及應(yīng)用價(jià)值.
互聯(lián)網(wǎng)
Objective To explore the prognostic evaluation of primary liver cancer after transcatheter arterial chemoembolization ( TACE ) operation.
目的探討原發(fā)性肝癌經(jīng)導(dǎo)管動(dòng)脈栓塞化療 ( TACE ) 術(shù)后的預(yù)后評(píng)估.
互聯(lián)網(wǎng)
Conclusion Unresectable primary cancer should be treated by the TACE oriented comprehensive therapy.
結(jié)論不能手術(shù)切除的原發(fā)性肝癌應(yīng)施以TACE為主的綜合治療.
互聯(lián)網(wǎng)
Objective : To observe the variation of blood stasis before and after transcatheter arterial chemoembolization ( TACE ).
目的: 觀察肝動(dòng)脈化療栓塞術(shù) ( TACE ) 前后肝癌患者血瘀程度的變化情況.
互聯(lián)網(wǎng)
TACE via the IPA is a safe and efficient for HCC.
經(jīng)膈下動(dòng)脈介入化療栓塞原發(fā)性肝癌是安全有效的介入治療方法.
互聯(lián)網(wǎng)
Results: The serum TAF level dropped markedly after TACE of patients with PHC ( P < 0.05 ).
結(jié)果: 全部病例TAF術(shù)前、術(shù)后水平均高于正常水平 ( P<0.05 ).
互聯(lián)網(wǎng)